Name: Advanced Therapies UK 2027
Start: 2027-03-09T09:00+00:00
End: 2027-03-10T17:00+00:00
Location: ExCel

9 - 10 March 2027
ExCeL, London

ADVANCING CELL AND GENE THERAPIES

SPONSOR OR EXHIBIT

GET YOUR TICKET NOW

THE FUTURE OF ADVANCED THERAPIES

3,000+

Attendees

300+

Speakers

200+

Exhibitors

75+

Biotech Start-Ups

2

Days

Our Speakers

Eric David
Chief Executive Officer of Gene Therapy
BridgeBio

Eric David speaking at Advanced Therapies Congress

Dame Molly Stevens
John Black Professor of Bionanoscience
University of Oxford

Molly Morag Stevens speaking at Advanced Therapies Congress

Bobby Gaspar
CEO
Orchard Therapeutics

Bobby Gaspar speaking at Advanced Therapies Congress

Nick France
Vice President, Head: Genomic Medicine Development Unit
Alexion, Astrazeneca Rare Disease

Nick France speaking at Advanced Therapies Congress

Chris Williams
Chief Business Officer
Autolus

Chris Williams speaking at Advanced Therapies Congress

Peter Andersen
Chief Research & Development Officer
Treefrog Therapeutics

Peter Andersen speaking at Advanced Therapies Congress

Jaap Boelens
Chief Stem Cell Transplantation & Cellular Therapies Pediatrics
Memorial Sloan Kettering Cancer Center

Jaap Boelens speaking at Advanced Therapies Congress

Lilian Hook
Director Cell, Apheresis & Gene Therapies
NHS Blood and Transplant

Lilian Hook speaking at Advanced Therapies Congress

Claire Kerridge
Head of Gene Therapy
MHRA

Claire Kerridge speaking at Advanced Therapies Congress

Mark Battaglini
Chief Strategy Officer
Alliance for Regenerative Medicine

Mark Battaglini speaking at Advanced Therapies Congress

Nan Zhang
Chief, Cell Therapy Manufacturing
National Institutes of Health

Nan Zhang speaking at Advanced Therapies Congress

Joshi Venugopal
Global Head Drug Development Operation Executive
Novartis

Joshi Venugopal speaking at Advanced Therapies Congress

Catherine Burns
BBC Health Correspondent
BBC News

Catherine Burns speaking at Advanced Therapies Congress

Luke Henry
Chief Business Officer
Quell Therapeutics Ltd

Luke Henry speaking at Advanced Therapies Congress

Ashleigh Furlong
Health Reporter
Bloomberg News

Ashleigh Furlong speaking at Advanced Therapies Congress

Lara Campana
SVP, Head of Research and Translational Science
Resolution Therapeutics

Lara Campana speaking at Advanced Therapies Congress

About Advanced Therapies Congress

The Advanced Therapies Congress is Europe's largest commercial cell and gene therapy conference and exhibition. The event is for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies that are driving the industry forward.

The conferences brings together a community of 3,300 global executives at ExCeL London, to be inspired by 300 speakers and 75 start-ups over 2 incredible days. The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and start- up companies, researchers, clinicians, academics, HTAs, payers and regulators.

Apply to Sponsor/Exhibit

What is the Advanced Therapies Congress?

Conference

The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development with 8 tracks of content over 2 days.

SEE SPEAKERS

Exhibition

50 leading solution providers to meet your needs across all stages of cell and gene therapy development

DOWNLOAD PROSPECTUS

Networking

Connect with thousands of cell and gene therapy experts in 12+ hours of built-in 1-2-1 networking

GET YOUR TICKET

Covering the entire pipeline of ATMPs

The Advanced Therapies Congress brings together speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and startup companies, researchers, clinicians, academics, HTAs, payers, regulators.

Get your ticket now

Content Themes

Ensuring clinical success - Tackling large scale regulatory challenge - Finding the right framework for reimbursement and market access - Cross-border healthcare - Outcome based agreements

Autologous vs allogeneic - Tackling solid tumours - Combination therapy - CAR-T, NK, Gamma-Delta cells - Patient stratification and precision medicine approaches

Stem cells - Regenerative Medicine - MSCs vs iPSCs - Cord blood advancements

Next generation of gene therapy - Moving from rare to more common diseases - Tackling immunogenicity - Rare diseases & orphan drugs - Novel gene delivery systems

Automation & closed systems - Scaling up to commercial level - Keeping costs low - In house vs outsourcing

Continuous manufacturing - Scaling up for commercial production - In house vs outsourcing

Ensuring clinical success - Clinical and nursing perspectives - Moving from clinical to commercial

Latest cutting edge technology - Latest academic research - Safety & ethics

Immunotherapy for solid tumours - AI in oncology - Precision medicine

Logistics, transportation, distribution & cold chain - Moving from clinical to commercial - Patient experience - Supply chain - Point of care delivery

Tackling large scale regulatory challenges - Patient informed policy decisions

Latest in academic research - Latest cutting-edge technologies success - Tackling large scale regulatory challenges - Finding the right framework for reimbursement and market access - Cross-border healthcare - Outcome based agreements

Company presentations from exciting new start-ups - Investor perspectives

Challenges in clinical adoption, patient pathways and improving accessibility, Initial and ongoing care

"Great people and content; lots of opportunities to dialogue with experts on our sector"

– President & CEO, NKILT Therapeutics

"The most momentous leaps in CGT won’t come from solitary strides, but from a collective momentum of aligned visionaries. This conference will be a catalyst towards this goal."

– General Manager and Head of Europe, Novartis Gene Therapies

"Great mix of suppliers, manufacturers, Sponsors, exhibitors and presentations"

– Vice President of Operations, Adaptimmune

Join us in London | 9 - 10 March 2027

GET YOUR TICKET NOW

9 - 10 March 2027
ExCeL, London

ADVANCING CELL AND GENE THERAPIES

THE FUTURE OF ADVANCED THERAPIES

3,000+

300+

200+

75+

2

Our Speakers

About Advanced Therapies Congress

Sponsors include

What is the Advanced Therapies Congress?

Covering the entire pipeline of ATMPs

Content Themes

Join us in London | 9 - 10 March 2027

Get Involved with Advanced Therapies Congress

To sponsor or exhibit

Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

To speak

Chris Shanks
Chris.Shanks@terrapinn.com
+44 207 092 1150

Created by

9 - 10 March 2027 ExCeL, London

ADVANCING CELL AND GENE THERAPIES

THE FUTURE OF ADVANCED THERAPIES

3,000+

300+

200+

75+

2

Our Speakers

About Advanced Therapies Congress

Sponsors include

What is the Advanced Therapies Congress?

Covering the entire pipeline of ATMPs

Content Themes

Join us in London | 9 - 10 March 2027

Get Involved with Advanced Therapies Congress

To sponsor or exhibit

Ashlea Foster ashlea.foster@terrapinn.com +44 208 164 3032

To speak

Chris Shanks Chris.Shanks@terrapinn.com +44 207 092 1150

Created by

9 - 10 March 2027
ExCeL, London

Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

Chris Shanks
Chris.Shanks@terrapinn.com
+44 207 092 1150